Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years

C. Angelini, C. Angelini, C. Semplicini, C. Semplicini, S. Ravaglia, S. Ravaglia, B. Bembi, B. Bembi, S. Servidei, S. Servidei, E. Pegoraro, E. Pegoraro, M. Moggio, M. Moggio, M. Filosto, M. Filosto, E. Sette, E. Sette, G. Crescimanno, G. Crescimanno, P. Tonin, P. Tonin, R. Parini, R. Parini, L. Morandi, L. Morandi, G. Marrosu, G. Marrosu, G. Greco, G. Greco, O. Musumeci, O. Musumeci, G. Di Iorio, G. Di Iorio, G. Siciliano, G. Siciliano, M. A. Donati, M. A. Donati, F. Carubbi, F. Carubbi, M. Ermani, M. Ermani, T. Mongini, T. Mongini, A. Toscano, A. Toscano
  • Journal of Neurology, November 2011, Springer Science + Business Media
  • DOI: 10.1007/s00415-011-6293-5

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1007/s00415-011-6293-5

The following have contributed to this page: Prof Corrado Angelini